Group 1 - TaiLin Bio (SZ 300813) announced on September 22 that its wholly-owned subsidiary, Zhejiang TaiLin Life Sciences Co., Ltd., has recently obtained 5 patent certificates [1] - The patents include "Gas Sterilization Resistance Detection Device and Method for Zero Rise Period of Gas Concentration" and "Plankton Pretreatment Equipment (1)" [1] - For the fiscal year 2024, TaiLin Bio's revenue composition is projected to be 90.04% from the pharmaceutical industry and 9.96% from other businesses [1] Group 2 - As of the report, TaiLin Bio has a market capitalization of 4.5 billion yuan [1]